AU1682602A - Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus - Google Patents

Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus

Info

Publication number
AU1682602A
AU1682602A AU1682602A AU1682602A AU1682602A AU 1682602 A AU1682602 A AU 1682602A AU 1682602 A AU1682602 A AU 1682602A AU 1682602 A AU1682602 A AU 1682602A AU 1682602 A AU1682602 A AU 1682602A
Authority
AU
Australia
Prior art keywords
subunit
polypeptides
sodium
treatment
febrile seizures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1682602A
Inventor
Robyn Heather Wallace
John Charles Mulley
Samuel Frank Berkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionomics Ltd
Original Assignee
Bionomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR2203A external-priority patent/AUPR220300A0/en
Application filed by Bionomics Ltd filed Critical Bionomics Ltd
Priority to NZ550702A priority Critical patent/NZ550702A/en
Priority to AU1682602A priority patent/AU1682602A/en
Publication of AU1682602A publication Critical patent/AU1682602A/en
Pending legal-status Critical Current

Links

AU1682602A 2000-12-20 2001-12-20 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus Pending AU1682602A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ550702A NZ550702A (en) 2000-12-20 2001-12-20 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
AU1682602A AU1682602A (en) 2000-12-20 2001-12-20 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR2203A AUPR220300A0 (en) 2000-12-20 2000-12-20 New epilepsy gene
AU1682602A AU1682602A (en) 2000-12-20 2001-12-20 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
PCT/AU2001/001648 WO2002050096A1 (en) 2000-12-20 2001-12-20 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus

Publications (1)

Publication Number Publication Date
AU1682602A true AU1682602A (en) 2002-07-01

Family

ID=25616660

Family Applications (1)

Application Number Title Priority Date Filing Date
AU1682602A Pending AU1682602A (en) 2000-12-20 2001-12-20 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus

Country Status (1)

Country Link
AU (1) AU1682602A (en)

Similar Documents

Publication Publication Date Title
GB2370731B (en) Telecommumination device with improved call-priority notification function and method of notification of call-priority
AU2002322388A8 (en) Defensin polynucleotides and methods of use
EP1372739A4 (en) Stabilized therapeutic and imaging agents
IL149251A0 (en) Diagnosis and treatment of cardiovascular conditions
AU2002359512A8 (en) Belts and methods of use thereof
AU6723401A (en) Antimicrobial peptides and methods of use thereof
EP1438387A4 (en) Methods of making glycomolecules with enhanced activities and uses thereof
GB0130465D0 (en) Baler and enveloping apparatus
AU2003207824A8 (en) K-type polarizer and preparation thereof
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
HUP0201966A3 (en) Methods of treatment and drug screening methods
LU91070B1 (en) Treatment and diagnosis of insulin resistant states
AU1682602A (en) Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
AU2002366441A8 (en) Enhanced photo-emf sensor with high bandwidth and large field of view
AU2002216826A1 (en) Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
GB0201151D0 (en) Ground-connection structure ground-connecting member and ground-connection met d
PL370346A1 (en) An enantiomerically pure diarylmethylpiperazine and methods of using same
GB2381900B (en) Acquisition and organization of digital images
EP1386963A4 (en) Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity
EP1367123A4 (en) Neurotonin and use thereof
PL357906A1 (en) Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
IL149533A0 (en) Treatment of sle with dehydropiandrosterone
EP1392460A4 (en) Hydrogenfluorides of aminosilanols and their use
GB2371257B (en) Relative orientation of bodies and associated apparatus